Federal project improves myocardial infarction treatment accessibility, increasing intervention rates and reducing mortality.
Myocardial infarction (MI) continues to retain the status of one of the key lifethreatening cardiovascular diseases with a high morbidity and mortality, including the working-age population. As part of the federal project "Control of Cardiovascular Diseases" in the Russian Federation in 2019-2024, a large-scale modernization of healthcare system for acute coronary syndrome and MI was carried out. The network of regional vascular centers was expanded and patient routing was optimized, which made it possible to increase the coverage of percutaneous coronary intervention for ST-segment elevation MI from 56% to 77%, and for NSTEMI — from 21% to 48%, and to achieve a decrease in mortality from MI per 100 thousand people by 19,6%, and inhospital mortality from MI — by 32%. However, interregional differences remain, and therefore further work is needed to improve the availability and timing of reperfusion therapy. Within the federal project "Control of Cardiovascular Diseases" of the National Project "Long and Active Life", the target indicator of reperfusion therapy coverage of patients with MI hospitalized within the first 24 hours from the disease onset will be monitored. Its level should reach 95% by 2030. Implementation of additional measures will reduce the differentiation of indicators between regions, reduce cardiovascular mortality and achieve national goals to increase life expectancy.
No takes yet. Share an insight, caveat, or question.
Kamkin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: